Effectiveness and B-memory Cell Response to QHPV Vaccine 9-years Post-vaccination Among HIV-infected Boys and Girls

NCT04920526 · clinicaltrials.gov ↗

UNKNOWN

Status

135

Enrollment

OTHER

Sponsor class

Conditions

HPV-Related Carcinoma

Interventions

DRUG: Quadrivalent HPV [Type 6, 11, 16 and 18] L1 Virus-Like Particle Vaccine

Sponsor

Kenya Medical Research Institute

Collaborators

[object Object]